Pharmac backtracks on plan to fund lung cancer drug Keytruda
The move has dashed hopes that Keytruda would soon be publicly funded for lung cancer - New Zealand's biggest cancer killer. RNZ has obtained documents showing Pharmac had planned to offer a Request for Proposals, or RFP, where drug companies are asked to pitch their products and prices, but has put that on hold due to budget constraints. Chief executive Sarah Fitt told RNZ that Pharmac was concerned about rising drug prices worldwide in the Covid-19 pandemic and that it could not commit to funding the drug now - but still hoped to in the future.
Lung cancer patients and their advocates are devastated and said they had been given false hope. Keytruda is available in New Zealand but patients must fund it themselves. "So what we now have is 30 lung cancer patients continuing to die prematurely every week and you have to ask yourself, is that acceptable?" Fitt said funding a drug like Keytruda for lung cancer would have cost hundreds of millions over the next five years and Pharmac could not commit to that given the Covid-19 outbreak.
========================================================
We're talking new year resolutions...
Tidying the house before going to bed each night, meditating upon waking or taking the stairs at work.
What’s something quick, or easy, that you started doing that made a major positive change in your life?
Poll: Would you rather: Christmas in summer forever or winter forever?
Just a bit of a fun poll to get you thinking.
If you had to live out your Christmas days, would you prefer it was a summer Christmas or a winter Christmas?
-
63.1% Summer
-
35.5% Winter
-
1.4% Other - I'll share below
What word sums up 2024, neighbours?
If 2020 was the year of lockdowns, banana bread, and WFH (work from home)....
In one word, how would you define 2024?
We're excited to see what you come up with!
Loading…
